This inventor holds 7 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Protiva Biotherapeutics, Inc., The United States of America. Active years: 1992-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
6 out of 3,696 
2 out of 46 
1 out of 255 
Years Active: 1992-2015
Title: Snorri S Thorgeirsson: Innovator in Cancer Gene Therapy
Introduction
Snorri S Thorgeirsson is a prominent inventor based in Bethesda, MD (US). He has made significant contributions to the field of cancer research through his innovative inventions. With a total of 7 patents, Thorgeirsson has focused on developing therapeutic methods to combat cell proliferative disorders, particularly cancer.
Latest Patents
Thorgeirsson's latest patents include groundbreaking work on compositions and methods for silencing genes expressed in cancer. One of his notable inventions provides therapeutic nucleic acids, such as interfering RNA (e.g., siRNA), that target the expression of genes associated with tumorigenesis and cell transformation. This invention also encompasses lipid particles that comprise therapeutic nucleic acids, along with methods for their delivery and administration for treating cancer. Another significant patent focuses on silencing the CSN5 gene expression using interfering RNA. This invention offers compositions that target CSN5 gene expression and methods for using these compositions to silence the gene, which is crucial for treating cell proliferative disorders like cancer.
Career Highlights
Throughout his career, Thorgeirsson has worked with esteemed organizations, including the United States Department of Health and Human Services and Protiva Biotherapeutics, Inc. His work has been instrumental in advancing therapeutic strategies for cancer treatment.
Collaborations
Thorgeirsson has collaborated with notable colleagues, including Bao-Zhu Yuan and Nicholas Popescu, contributing to the development of innovative cancer therapies.
Conclusion
Snorri S Thorgeirsson's contributions to cancer gene therapy through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for new therapeutic approaches to combat cancer effectively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile